Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 6
Submit an article Journal homepage
494
Views
3
CrossRef citations to date
0
Altmetric
Nephrology

Efficacy and safety of CKD-11101 (darbepoetin-alfa proposed biosimilar) compared with NESP in anaemic chronic kidney disease patients not on dialysis

Jong Hoon LeeDivision of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea;
,
Byung Ha ChungDivision of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea;
,
Kwon Wook JooDivision of Nephrology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea;
,
Sug Kyun ShinDivision of Nephrology, Department of Internal Medicine, National Health Insurance Corporation IIsan Hospital, Goyang, Korea;
,
Yong-Lim KimDivision of Nephrology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea;
,
Ki Young NaDivision of Nephrology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea;
,
Jun-young DoDivision of Nephrology, Department of Internal Medicine, Yeungnam University School of Medicine, Daegu, Korea;
,
Su-Kil ParkDivision of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
,
Byung Chul ShinDivision of Nephrology, Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Korea;
,
Jong Soo LeeDivision of Nephrology, Department of Internal Medicine, Ulsan University Hospital, Ulsan, Korea;
,
Yang-Wook KimDivision of Nephrology, Department of Internal Medicine, Inje University, Haeundae Paik Hospital, Busan, Korea;
,
Soo Wan KimDivision of Nephrology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea;
,
Kang Wook LeeDivision of Nephrology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, South Korea;
,
Gun Woo KangDivision of Nephrology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea;
,
Won Suk AnDivision of Nephrology, Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea;
,
Gyu-Tae ShinDivision of Nephrology, Department of Nephrology, Ajou University School of Medicine, Suwon, Korea;
,
Seungyeup HanDivision of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea
&
Chul Woo YangDivision of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; Correspondence[email protected]
 show all
Pages 1111-1118 | Received 30 Apr 2018, Accepted 14 Dec 2018, Published online: 17 Jan 2019

References

  • Barbone FP, Johnson DL, Farrell FX, et al. New epoetin molecules and novel therapeutic approaches. Nephrology. 1999;14(Suppl 2):80–84.
  • Downey P. Recombinant human erythropoietin as a treatment for anemia of prematurity. J Perinat Neonat Nur. 1997;11(3):57–68.
  • Paganini EP. Overview of anemia associated with chronic renal disease: primary and secondary mechanisms. Semin Nephrol. 1989;9(1 Suppl 1):3–8.
  • Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28(1):53–61.
  • Roth D, Smith RD, Schulman G, et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis. 1994;24(5):777–784.
  • Cody JD, Hodson EM. Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis. Cochrane DB Syst Rev. 2016;20(1):Cd003266.
  • Portolés JM, de Francisco ÁLM, Górriz JL, et al. Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study: new strategies to prevent cardiovascular risk in chronic kidney disease. Kidney Int. 2008;74:S82–S87.
  • Hertel JE, Locay HR, Scarlata DS, et al. Darbepoetin alfa administration to achieve and maintain target hemoglobin levels for 1 year in patients with chronic kidney disease. Mayo Clin Proc. 2006;81(9):1188–1194.
  • Agarwal AK, Silver MR, Reed JE, et al. An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis. J Intern Med. 2006;260(6):577–585.
  • Toto RD, Pichette V, Navarro J, et al. Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration. Am J Nephrol. 2004;24(4):453–460.
  • Hertel J, Locay H, Scarlata D, et al. Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from simplify the treatment of anemia with Aranesp (STAAR). Am J Nephrol. 2006;26(2):149–156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.